This profile was last updated on .
Is this you? Claim your profile.
Aptuit Consulting Inc
91 Hartwell Ave
Aptuit Consulting is comprised of experienced drug development professionals in the US and Europe with proven track records in managing the complex process of advancing new medicines (small molecules and proteins) and devices from the later stages of disc...
Find other employees at this company (1)
(148 Total References)
History | Aptuit Consulting
Dr William D Kerns named President of Aptuit Consulting
"Our consultants have deep expertise in all facets of drug development and the collaboration with TLC in filing the first anti-cancer IND for a Taiwanese company is representative of the collaborative work we do in supporting many emerging companies, globally," noted Dr. William Kerns, Managing Director, Aptuit Consulting.
"Ms. Larson-Marlowe brings strong experience in biotech/pharma program and project management which will further broaden the level of leadership and support Aptuit Consulting can provide to our customers" commented Dr. William Kerns, President of Aptuit Consulting.
Aptuit Consulting Announces Dr. William Kerns to Head Aptuit Consulting | Tell me about it
Announces Dr. William Kerns
to Head Aptuit Consulting
Announces Dr. William Kerns
to Head Aptuit Consulting and Mark Nedelman as Director of Business Development
Dr. William Kerns has been named President, Aptuit Consulting Inc., and Mark Nedelman has been named Director of Business Development.
Following Aptuit Consulting Inc.'s significant growth in scale and revenues since its inception in May 2006, with major advances in the Legal practice and Drug Development areas, Bill Kerns will assume the role of President, Aptuit Consulting, Bill will continue to operate out of the Lexington, MA office.
has been instrumental in the growth of the Consulting group and will continue to be as Aptuit Consulting
develops new markets globally.
team will also take a leading role in Aptuit INDiGO™, our new program providing accelerated drug development from API through proof-of-concept clinical development.
Bill has 25 years of experience in Pharmaceutical Research and Development having held senior executive positions in Preclinical Development at SmithKlineFrench, SmithKlineBeecham and Eisai Pharma during his pharmaceutical career.
In 2001, he started of Pharma Consulting Inc. (PCI), a successful consulting practice focused on assisting biopharmaceutical companies in drug development and regulatory strategy from manufacturing through early Phase 2.
His has worked with companies in all major markets and all disease areas.
CABA (Chinese-American BioMedical Association) Website - Events - Events
12:10 - 12:30 PM Dr. William Kerns, President, Aptuit Consulting Inc., Lexington, MA
"Virtual Drug Development"